Sibutramine in clinical practice

9Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The role of sibutramine as an effective adjunct to diet and exercise in weight management programmes has been proven in clinical trials. Although the reality of managing obesity in clinical practice is very different from that of a controlled clinical trial, there is good evidence that sibutramine is an easy-to-use and highly effective additional therapy when used in everyday practice to manage obesity and its complications. It is possible to predict which patients will respond well to sibutramine treatment, and to modify programmes and support to ensure the best outcome for patients, whatever their clinical circumstances. © 2001 Nature Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Finer, N. (2001). Sibutramine in clinical practice. International Journal of Obesity, 25, S12–S15. https://doi.org/10.1038/sj.ijo.0801932

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free